Circulating Levels of IL-13, TGF-β1, and Periostin as Potential Biomarker for Coronary Artery Disease with Acute Heart Failure.

Qiu X, Ma F, Zhang H

Open source

DOI
10.1155/2021/1690421
Published
2021
Container
Evidence-based complementary and alternative medicine : eCAM
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2021/1690421,
  title = {Circulating Levels of IL-13, TGF-β1, and Periostin as Potential Biomarker for Coronary Artery Disease with Acute Heart Failure.},
  author = {Qiu X and Ma F and Zhang H},
  year = {2021},
  journal = {Evidence-based complementary and alternative medicine : eCAM},
  doi = {10.1155/2021/1690421},
  url = {https://doi.org/10.1155/2021/1690421}
}

RIS

TY  - JOUR
TI  - Circulating Levels of IL-13, TGF-β1, and Periostin as Potential Biomarker for Coronary Artery Disease with Acute Heart Failure.
AU  - Qiu X
AU  - Ma F
AU  - Zhang H
PY  - 2021
JO  - Evidence-based complementary and alternative medicine : eCAM
DO  - 10.1155/2021/1690421
UR  - https://doi.org/10.1155/2021/1690421
ER  - 

APA

X, Q., F, M., & H, Z. (2021). Circulating Levels of IL-13, TGF-β1, and Periostin as Potential Biomarker for Coronary Artery Disease with Acute Heart Failure.. Evidence-based complementary and alternative medicine : eCAM. https://doi.org/10.1155/2021/1690421

Source records